These analyses suggest that the H-IDO1M cluster exhibits higher immune infiltration than the L-IDO1M cluster, especially CD8+ T cells and M1 macrophages, which might be a favorable condition for immunotherapy in patients with CRC. The gene discussed is CD8A; the disease is colorectal carcinoma.